Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829809) titled 'Serum Adropin as an Indicator of Endothelial Dysfunction and Disease Severity in Obstructive Sleep Apnea in Obese Patients' on Sept. 15.

Study Type: Observational

Primary Sponsor: Aswan University

Condition: Adropin In Patients of OSA

Intervention: Diagnostic Test: Adropin

Recruitment Status: Not recruiting

Date of First Enrollment: September 15, 2026

Target Sample Size: 80

To know more, visit https://clinicaltrials.gov/study/NCT07829809

Disclaimer: Curated by HT Syndication....